Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MaxCyte (MXCT)

Price 266.00p on 21-11-2024 at 17:47:40
Change 4.00p 1.53%
Buy 270.00p
Sell 262.00p
Buy / Sell MXCT Shares
Last Trade: Unknown 5,544.00 at 269.4374p
Day's Volume: 54,807
Last Close: 266.00p
Open: 262.00p
ISIN: US57777K1060
Day's Range 262.00p - 266.00p
52wk Range: 256.00p - 420.00p
Market Capitalisation: £281m
VWAP: 268.48419p
Shares in Issue: 105m

Recent Trades History MaxCyte (MXCT)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 5,544 269.4374p Currency Conversion
OTC Trade
17:47:40 - 21-Nov-24
Unknown* 1,122 269.4374p Currency Conversion
OTC Trade
17:47:40 - 21-Nov-24
Unknown* 18,881 261.00p SI Trade
16:27:58 - 20-Nov-24
Unknown* 3,000 266.00p OTC Trade
17:05:52 - 21-Nov-24
Unknown* 484 266.00p OTC Trade
17:05:37 - 21-Nov-24
Unknown* 300 272.59796p Currency Conversion
OTC Trade
16:20:52 - 21-Nov-24
Unknown* 800 272.75598p Currency Conversion
OTC Trade
16:20:52 - 21-Nov-24
Buy* 3,000 269.20p Ordinary
16:20:46 - 21-Nov-24
Buy* 484 266.50p Ordinary
16:19:36 - 21-Nov-24
Sell* 1,460 263.001p Ordinary
16:18:45 - 21-Nov-24

Share Price History for MaxCyte

Time period:
to
Date Open High Low Close Volume

Share News for MaxCyte

MaxCyte third-quarter profit falls amid surging costs

8th Nov 2024 14:41

(Alliance News) - MaxCyte Inc on Thursday said profit fell in the third quarter despite revenue growth, as costs increase more than 80%. Read More

UK earnings, trading statements calendar - next 7 days

30th Oct 2024 15:08

Read More

MaxCyte touts strategic platform license deal with Kamau Therapeutics

16th Sep 2024 10:33

(Alliance News) - MaxCyte Inc on Monday celebrated the signing of a strategic platform license agreement with Kamau Therapeutics, a clinical-stage stem cell therapy gene correction company. Read More

MaxCyte reaffirms guidance as revenue jumps 24% in first half

7th Aug 2024 14:10

(Alliance News) - MaxCyte Inc on Wednesday said loss narrowed in the first half amid growing revenue and the signing of new partnership agreements. Read More

UK earnings, trading statements calendar - next 7 days

30th Jul 2024 13:57

Read More

FTSE 100 Latest
Value8,149.27
Change64.20

Login to your account

Forgot Password?

Not Registered